Publicaciones (1.016) Publicaciones en las que ha participado algún/a investigador/a

2013

  1. 'When did my tremor start?': Can essential tremor patients pinpoint their disease onset?

    Neuroepidemiology

  2. 2013 ESC guidelines on the management of stable coronary artery disease

    European Heart Journal, Vol. 34, Núm. 38, pp. 2949-3003

  3. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219

  4. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1747-1755

  5. 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Arthritis and Rheumatism, Vol. 65, Núm. 11, pp. 2737-2747

  6. 213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

    European Heart Journal, Vol. 34, Núm. 29, pp. 2281-2329

  7. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 11, pp. 1870-1876

  8. 3D color-Doppler echocardiography and chronic aortic regurgitation: A novel approach for severity assessment

    International Journal of Cardiology, Vol. 166, Núm. 3, pp. 640-645

  9. A case of rhino-orbito-cerebral mucormycosis in a non-diabetic HIV patient with metabollic acidosis

    HIV and AIDS Review, Vol. 12, Núm. 3, pp. 73-75

  10. A comprehensive, national survey of spirometry in Spain: Current bottlenecks and future directions in primary and secondary care

    Chest, Vol. 144, Núm. 2, pp. 601-609

  11. A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation

    American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500

  12. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control

    Leukemia, Vol. 27, Núm. 10, pp. 2056-2061

  13. A new approach to grading and treating COPD based on clinical phenotypes: Summary of the Spanish COPD guidelines (GesEPOC)

    Primary Care Respiratory Journal, Vol. 22, Núm. 1, pp. 117-121

  14. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

    Clinical Microbiology and Infection, Vol. 19, Núm. 1, pp. 56-61

  15. A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

    European Journal of Cancer, Vol. 49, Núm. 18, pp. 3763-3772

  16. A profibrotic role for thymic stromal lymphopoietin in Systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 12, pp. 2018-2029

  17. A propósito de la alopecia

    Glosa

  18. A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer

    Journal of Thoracic Oncology, Vol. 8, Núm. 3, pp. 329-337

  19. A randomized phase II non-comparative study of pemetrexed carboplatin and gemcitabine vinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients

    International Journal of Oncology, Vol. 42, Núm. 5, pp. 1778-1785

  20. A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

    Annals of Oncology, Vol. 24, Núm. 7, pp. 1777-1785